atg-based immunosuppressive therapy in elderly patients with aplastic anemia
Published 1 year ago • 3.9K plays • Length 1:42Download video MP4
Download video MP3
Similar videos
-
3:42
aplastic anemia: treatment options in 2019
-
5:13
factors determining the effectiveness of treatment with atg following transplantation
-
3:01
recent advancements in the treatment of aplastic anemia
-
2:33
aplastic anemia updates: race, the role of anabolic steroids, clonal architecture & more
-
5:35
exciting new immunosuppressive therapy treatment for aplastic anaemia
-
1:59
phase i study of pevonedistat, azacitidine, and venetoclax in patients with r/r aml
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
2:11
update on phase i/ii study of azacitidine, venetoclax and gilteritinib in patients with flt3 aml
-
1:03
10-day astx727 (decitabine/cedazuridine) with venetoclax in the treatment of r/r aml
-
11:33
treatment algorithm for low-risk mds
-
3:23
parachute trial: atg in hcst
-
0:45
difference between quality of life & patient-reported outcomes
-
2:16
gvhd prophylaxis post-allosct: ptcy versus atg
-
1:52
aml19 update: improvement in os in patients with npm1-mutated aml treated with flag-ida-go
-
1:19
new treatments for aml
-
1:22
managing cytopenias following jak inhibitor treatment & achieving true disease modification in mf
-
0:52
the role and clinical use of tpo receptor agonists in the treatment of itp
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸